141 related articles for article (PubMed ID: 37550093)
1. Associations of multiple genetic variations with plasma levels of Von Willebrand Factor and clinical phenotype in Iranian patients with Von Willebrand disease type 1.
Zafarani A; Tabibian S; Barati M; Ghodratnia E; Safa M
Transfus Apher Sci; 2023 Oct; 62(5):103766. PubMed ID: 37550093
[TBL] [Abstract][Full Text] [Related]
2. CLEC4M and STXBP5 gene variations contribute to von Willebrand factor level variation in von Willebrand disease.
Sanders YV; van der Bom JG; Isaacs A; Cnossen MH; de Maat MP; Laros-van Gorkom BA; Fijnvandraat K; Meijer K; van Duijn CM; Mauser-Bunschoten EP; Eikenboom J; Leebeek FW;
J Thromb Haemost; 2015 Jun; 13(6):956-66. PubMed ID: 25832887
[TBL] [Abstract][Full Text] [Related]
3. Effect of genetic variation in STXBP5 and STX2 on von Willebrand factor and bleeding phenotype in type 1 von Willebrand disease patients.
van Loon JE; Sanders YV; de Wee EM; Kruip MJ; de Maat MP; Leebeek FW
PLoS One; 2012; 7(7):e40624. PubMed ID: 22792389
[TBL] [Abstract][Full Text] [Related]
4. The role of genetics in the pathogenesis and diagnosis of type 1 Von Willebrand disease.
Flood VH; Garcia J; Haberichter SL
Curr Opin Hematol; 2019 Sep; 26(5):331-335. PubMed ID: 31261173
[TBL] [Abstract][Full Text] [Related]
5. Genetic Variation in the Syntaxin-Binding Protein STXBP5 in Type 1 von Willebrand Disease Patients.
Lind-Halldén C; Manderstedt E; Carlberg D; Lethagen S; Halldén C
Thromb Haemost; 2018 Aug; 118(8):1382-1389. PubMed ID: 29972863
[TBL] [Abstract][Full Text] [Related]
6. Unraveling the Influence of Common von Willebrand factor variants on von Willebrand Disease Phenotype: An Exploratory Study on the Molecular and Clinical Profile of von Willebrand Disease in Spain Cohort.
Borràs N; Garcia-Martínez I; Batlle J; Pérez-Rodríguez A; Parra R; Altisent C; López-Fernández MF; Costa Pinto J; Batlle-López F; Cid AR; Bonanad S; Cabrera N; Moret A; Mingot-Castellano ME; Navarro N; Pérez-Montes R; Marcellini S; Moreto A; Herrero S; Soto I; Fernández-Mosteirín N; Jiménez-Yuste V; Alonso N; de Andrés-Jacob A; Fontanes E; Campos R; Paloma MJ; Bermejo N; Berrueco R; Mateo J; Arribalzaga K; Marco P; Palomo Á; Castro Quismondo N; Iñigo B; Del Mar Nieto M; Vidal R; Martínez MP; Aguinaco R; Tenorio M; Ferreiro M; García-Frade J; Rodríguez-Huerta AM; Cuesta J; Rodríguez-González R; García-Candel F; Dobón M; Aguilar C; Corrales I; Vidal F
Thromb Haemost; 2020 Mar; 120(3):437-448. PubMed ID: 32135566
[TBL] [Abstract][Full Text] [Related]
7. Genetic variation in the C-type lectin receptor CLEC4M in type 1 von Willebrand Disease patients.
Manderstedt E; Lind-Halldén C; Lethagen S; Halldén C
PLoS One; 2018; 13(2):e0192024. PubMed ID: 29389944
[TBL] [Abstract][Full Text] [Related]
8. Clinical and laboratory phenotype variability in type 2M von Willebrand disease.
Doruelo AL; Haberichter SL; Christopherson PA; Boggio LN; Gupta S; Lentz SR; Shapiro AD; Montgomery RR; Flood VH
J Thromb Haemost; 2017 Aug; 15(8):1559-1566. PubMed ID: 28544236
[TBL] [Abstract][Full Text] [Related]
9. Correction of a dominant-negative von Willebrand factor multimerization defect by small interfering RNA-mediated allele-specific inhibition of mutant von Willebrand factor.
de Jong A; Dirven RJ; Oud JA; Tio D; van Vlijmen BJM; Eikenboom J
J Thromb Haemost; 2018 Jul; 16(7):1357-1368. PubMed ID: 29734512
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of slightly reduced von Willebrand factor activity.
Bykowska K; Ceglarek B
Pol Arch Intern Med; 2020 Mar; 130(3):225-231. PubMed ID: 31990275
[TBL] [Abstract][Full Text] [Related]
11. Severe, recessive type 1 is a discrete form of von Willebrand disease: the lesson learned from the c.1534-3C>A von Willebrand factor mutation.
Casonato A; Cattini MG; Barbon G; Daidone V; Pontara E
Thromb Res; 2015 Sep; 136(3):682-6. PubMed ID: 26251079
[TBL] [Abstract][Full Text] [Related]
12. The Association of Aging With Von Willebrand Factor Levels and Bleeding Risk in Type 1 Von Willebrand Disease.
Seaman CD; Ragni MV
Clin Appl Thromb Hemost; 2018 Apr; 24(3):434-438. PubMed ID: 28874064
[TBL] [Abstract][Full Text] [Related]
13. Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.
Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
Clin Appl Thromb Hemost; 2006 Jul; 12(3):277-95. PubMed ID: 16959681
[TBL] [Abstract][Full Text] [Related]
14. Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States.
Flood VH; Christopherson PA; Gill JC; Friedman KD; Haberichter SL; Bellissimo DB; Udani RA; Dasgupta M; Hoffmann RG; Ragni MV; Shapiro AD; Lusher JM; Lentz SR; Abshire TC; Leissinger C; Hoots WK; Manco-Johnson MJ; Gruppo RA; Boggio LN; Montgomery KT; Goodeve AC; James PD; Lillicrap D; Peake IR; Montgomery RR
Blood; 2016 May; 127(20):2481-8. PubMed ID: 26862110
[TBL] [Abstract][Full Text] [Related]
15. Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD).
Goodeve A; Eikenboom J; Castaman G; Rodeghiero F; Federici AB; Batlle J; Meyer D; Mazurier C; Goudemand J; Schneppenheim R; Budde U; Ingerslev J; Habart D; Vorlova Z; Holmberg L; Lethagen S; Pasi J; Hill F; Hashemi Soteh M; Baronciani L; Hallden C; Guilliatt A; Lester W; Peake I
Blood; 2007 Jan; 109(1):112-21. PubMed ID: 16985174
[TBL] [Abstract][Full Text] [Related]
16. Discrepant platelet and plasma von Willebrand factor in von Willebrand disease patients with p.Pro2808Leufs*24.
Bowman ML; Pluthero FG; Tuttle A; Casey L; Li L; Christensen H; Robinson KS; Lillicrap D; Kahr WHA; James P
J Thromb Haemost; 2017 Jul; 15(7):1403-1411. PubMed ID: 28453889
[TBL] [Abstract][Full Text] [Related]
17. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
[TBL] [Abstract][Full Text] [Related]
18. Similarity in joint and mucous bleeding syndromes in type 2N von Willebrand disease and severe hemophilia A coexisting with type 1 von Willebrand disease in two Chinese pedigrees.
Qin HH; Xing ZF; Wang XF; Ding QL; Xi XD; Wang HL
Blood Cells Mol Dis; 2014 Apr; 52(4):181-5. PubMed ID: 24351655
[TBL] [Abstract][Full Text] [Related]
19. Type 1 von Willebrand Disease in a Pediatric Patient Caused by a Novel Heterozygous Deletion of Exons 1 to 6 of the von Willebrand Factor Gene: A Case Report.
Lapić I; Radić Antolic M; Rogić D; Dejanović Bekić S; Coen Herak D; Bilić E; Zadro R
Lab Med; 2023 Jul; 54(4):434-438. PubMed ID: 36468906
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic pitfalls and conundrums in type 1 von Willebrand disease.
Sidonio RF; Lavin M
Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):618-623. PubMed ID: 36485079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
